Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04706221 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients
A NA study of Blood Loss, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04706221 is a NA study of Blood Loss that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 200 participants, above the 156-participant average among 8 other Blood Loss trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04706221, a NA study of Blood Loss, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to evaluate the the changes in the Relative Index in post abdominal or pelvic surgery patients on the Cardiac Monitor Model CM-1500.
Conditions Studied
Interventions
- DEVICE CM-1500
Study Locations (1)
North Carolina
- Wake Forest University - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2021-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04706221
The ClinicalTrials.gov registry entry for NCT04706221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 156-participant average among 8 other Blood Loss trials with a reported enrollment target (28% higher). The listed sponsor is Zynex Monitoring Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Loss appearing as the primary indexed condition, and to 1 intervention - of which CM-1500 is the first listed.
NCT04706221 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04706221 about?
NCT04706221 is a clinical study titled "Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients". The primary objective is to evaluate the the changes in the Relative Index in post abdominal or pelvic surgery patients on the Cardiac Monitor Model CM-1500.
What is the current status of trial NCT04706221?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2021-01-15. Estimated completion is 2021-11-29.
What conditions does trial NCT04706221 study?
This clinical trial studies the following conditions: Blood Loss.
What interventions are being tested in trial NCT04706221?
The interventions under investigation include: CM-1500 (DEVICE).
Who is sponsoring clinical trial NCT04706221?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04706221 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LBNP Tolerance With Skin Warming After Exercise Cold Stress
ACTIVE NOT RECRUITING · NA
-
Frozen Red Blood Cell Transfusions in Trauma Patients
COMPLETED · NA
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
RECRUITING · Phase 4
-
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
ACTIVE NOT RECRUITING · Phase 4
-
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.